Isotopen Technologien Munchen ITM Isotopen Technologien Munchen is a company that develops, produces, and supplies diagnostic and therapeutic radionuclides and radiopharmaceuticals for use in cancer treatment. | ![]() Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases. | ![]() Pharma Mar Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs. | Therapeia Therapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs. | ||
Founding Date | Founding Date 2004 | Founding Date 1997 | Founding Date 2011 | Founding Date 1986 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Garching bei München, DE HQ München, DE | Locations Lund, SE HQ | Locations Daix, FR HQ | Locations Colmenar Viejo, ES HQ Madrid, ES | Locations Dresden, DE HQ |
Employees | Employees 5403% increase | Employees 118 | Employees 114 | Employees 500 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 285.9 m | Valuation ($) 231 m | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr226.5m (FY, 2025) | Revenue (est.) €4.5m (FY, 2025) | Revenue (est.) €221.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods €12.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit kr226.6m (FY, 2025) | Gross profit €7.9m (FY, 2025) | Gross profit €232m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income (kr332.9m) (FY, 2025) | Net income (€354.1m) (FY, 2025) | Net income €75m (FY, 2025) | Net income N/A |

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View company
Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
View company
Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.
View companyTherapeia is a company that specializes in the development of diagnostic and therapeutic radiopharmaceuticals for unmet patient needs.
View company